Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Steven Sun"'
Autor:
John Gerecitano, Jodi Carey, Christopher Major, Peter Johnson, Songbai Wang, Pier Luigi Zinzani, Wyndham H. Wilson, Steven Sun, Jessica Vermeulen, S. Martin Shreeve, Louis M. Staudt, Laurie H. Sehn, Michael Schaffer, Brendan P. Hodkinson, Sriram Balasubramanian
Publikováno v:
Br J Haematol
We assessed the concordance between immunohistochemistry (IHC) and gene expression profiling (GEP) for determining diffuse large B-cell lymphoma (DLBCL) cell of origin (COO) in the phase III PHOENIX trial of rituximab plus cyclophosphamide, doxorubic
Autor:
Asher Chanan-Khan, Olga Samoilova, Charles Phelps, Michelle Mahler, Javier Loscertales, Dirceu Villa Villa, Ann Janssens, Andre Goy, M. Salman, Simon Rule, Claes Karlsson, Miguel A. Pavlovsky, Graeme Fraser, Angela Howes, Alexander Pristupa, Steven Sun, Marie-Sarah Dilhuydy, Abraham Avigdor, Paula Cramer, Panagiotis Panagiotidis, Nancy L. Bartlett, Sriram Balasubramanian, Jiří Mayer, Fatih Demirkan, R. Santucci Silva, Sebastian Grosicki, Halyna Pylypenko, Michael Hallek
Publikováno v:
Leukemia
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
We report follow-up results from the randomized, placebo-controlled, phase 3 HELIOS trial of ibrutinib+bendamustine and rituximab (BR) for previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) without deletion 17p. Ov
Autor:
Steven Sun, Weiping Liu, Gang An, Zhen Cai, Ming Qi, Lijuan Chen, Wei Li, Xue Yang, Xue Gai, Zheng Ge, Yafei Wang, Jin Lu, Ting Niu, Xi-Nan Cen, Chengcheng Fu, Jie Jin, Xiao-Jun Huang, Wenyu Liu, Jianda Hu, Weijun Fu
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(9)
Background Daratumumab plus bortezomib/dexamethasone (D-Vd) significantly improved outcomes versus Vd in patients with relapsed or refractory multiple myeloma (RRMM) in the phase 3 CASTOR study. We report the results of a prespecified interim analysi
Publikováno v:
Gynecologic Oncology. 95:1-8
Objective Provide long-term follow-up data for women treated in a randomized multicenter study of pegylated liposomal doxorubicin compared with topotecan. Methods Patients with epithelial ovarian cancer that recurred after or failed to respond to fir